Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 103923, 18 pages
http://dx.doi.org/10.1155/2014/103923
Review Article

Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues

1London Regional Cancer Program, London Health Sciences Centre, Room A4-931A 790 Commissioners Road East, London, ON, Canada N6A 4L6
2Department of Laboratory Medicine and Pathology, Masonic Comprehensive Cancer Center, Minneapolis, MN 55455, USA
3Division of Plastic and Reconstructive Surgery, University of Western Ontario, London, ON, Canada N6A 4V2

Received 25 April 2014; Accepted 4 July 2014; Published 4 August 2014

Academic Editor: George Tzanakakis

Copyright © 2014 Cornelia Tolg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Ballard, L. W. Gonzales, R. I. Godinez et al., “Surfactant composition and function in a primate model of infant chronic lung disease: Effects of inhaled nitric oxide,” Pediatric Research, vol. 59, no. 1, pp. 157–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Schäfer and S. Werner, “Cancer as an overhealing wound: an old hypothesis revisited,” Nature Reviews Molecular Cell Biology, vol. 9, no. 8, pp. 628–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Veiseh and E. A. Turley, “Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer,” Integrative Biology, vol. 3, no. 4, pp. 304–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Byun and K. Gardner, “Wounds that will not heal: Pervasive cellular reprogramming in cancer,” American Journal of Pathology, vol. 182, no. 4, pp. 1055–1064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Meng, J. Zhong, S. Liu, M. Murray, and A. M. Gonzalez-Angulo, “A new hypothesis for the cancer mechanism,” Cancer and Metastasis Reviews, vol. 31, no. 1-2, pp. 247–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Mukhtar, O. Nseyo, M. J. Campbell, and L. J. Esserman, “Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics,” Expert Review of Molecular Diagnostics, vol. 11, no. 1, pp. 91–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. V. Dieci, M. Arnedos, F. Andre, and J. C. Soria, “Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives,” Cancer Discovery, vol. 3, no. 3, pp. 264–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Polyak, “Pregnancy and breast cancer: the other side of the coin,” Cancer Cell, vol. 9, no. 3, pp. 151–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Radisky and L. C. Hartmann, “Mammary involution and breast cancer risk: transgenic models and clinical studies,” Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 181–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kobayashi, H. Sugiura, Y. Ando et al., “Reproductive history and breast cancer risk,” Breast Cancer, vol. 19, no. 4, pp. 302–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Ercan, P. J. van Diest, and M. Vooijs, “Mammary development and breast cancer: the role of stem cells,” Current Molecular Medicine, vol. 11, no. 4, pp. 270–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Stein, N. Salomonis, D. S. Nuyten, M. J. van de Vijver, and B. A. Gusterson, “A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis,” Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 99–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Monks and P. M. Henson, “Differentiation of the mammary epithelial cell during involution: Implications for breast cancer,” Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 159–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Lanigan, D. O'Connor, F. Martin, and W. M. Gallagher, “Molecular links between mammary gland development and breast cancer,” Cellular and Molecular Life Sciences, vol. 64, no. 24, pp. 3159–3184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Schedin, J. O'Brien, M. Rudolph, T. Stein, and V. Borges, “Microenvironment of the involuting mammary gland mediates mammary cancer progression,” Journal of Mammary Gland Biology and Neoplasia, vol. 12, no. 1, pp. 71–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Penn, A. O. Grobbelaar, and K. J. Rolfe, “The role of the TGF-beta family in wound healing, burns and scarring: a review,” International Journal of Burns and Trauma, vol. 2, no. 1, pp. 18–28, 2012. View at Google Scholar
  17. S. H. Phan, “Genesis of the myofibroblast in lung injury and fibrosis,” Proceedings of the American Thoracic Society, vol. 9, no. 3, pp. 148–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound repair and regeneration,” Nature, vol. 453, no. 7193, pp. 314–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Rhett, G. S. Ghatnekar, J. A. Palatinus, M. O'Quinn, M. J. Yost, and R. G. Gourdie, “Novel therapies for scar reduction and regenerative healing of skin wounds,” Trends in Biotechnology, vol. 26, no. 4, pp. 173–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. F. Diegelmann and M. C. Evans, “Wound healing: an overview of acute, fibrotic and delayed healing,” Frontiers in Bioscience, vol. 9, pp. 283–289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Rybinski, J. Franco-Barraza, and E. Cukierman, “The wound healing, chronic fibrosis, and cancer progression triad,” Physiological Genomics, vol. 46, no. 7, pp. 223–244, 2014. View at Google Scholar
  22. M. R. Namazi, M. K. Fallahzadeh, and R. A. Schwartz, “Strategies for prevention of scars: what can we learn from fetal skin?” International Journal of Dermatology, vol. 50, no. 1, pp. 85–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Van De Water, S. Varney, and J. J. Tomasek, “Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention,” Advances in Wound Care, vol. 2, no. 4, pp. 122–141, 2013. View at Google Scholar
  24. J. Mann and D. A. Mann, “Epigenetic regulation of wound healing and fibrosis,” Current Opinion in Rheumatology, vol. 25, no. 1, pp. 101–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Duffield, M. Lupher, V. J. Thannickal, and T. A. Wynn, “Host responses in tissue repair and fibrosis,” Annual Review of Pathology: Mechanisms of Disease, vol. 8, pp. 241–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Klingberg, B. Hinz, and E. S. White, “The myofibroblast matrix: Implications for tissue repair andfibrosis,” Journal of Pathology, vol. 229, no. 2, pp. 298–309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Fan and H. Liang, “Criculating fibrocytes: a potent cell population in antigen-presenting and wound healing,” Chinese Journal of Traumatology, vol. 13, no. 2, pp. 111–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. C. Keeley, B. Mehrad, and R. M. Strieter, “The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders,” Thrombosis and Haemostasis, vol. 101, no. 4, pp. 613–618, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Eyden, “The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 22–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Jiang, J. Liang, and P. W. Noble, “Hyaluronan as an immune regulator in human diseases,” Physiological Reviews, vol. 91, no. 1, pp. 221–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Barron and D. R. Rowley, “The reactive stroma microenvironment and prostate cancer progression,” Endocrine-Related Cancer, vol. 19, no. 6, pp. R187–R204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Togo, U. M. Polanska, Y. Horimoto, and A. Orimo, “Carcinoma-associated fibroblasts are a promising therapeutic target,” Cancers, vol. 5, no. 1, pp. 149–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Mao, E. T. Keller, D. H. Garfield, K. Shen, and J. Wang, “Stromal cells in tumor microenvironment and breast cancer,” Cancer and Metastasis Reviews, vol. 32, no. 1-2, pp. 303–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Hanahan and L. M. Coussens, “Accessories to the crime: functions of cells recruited to the tumor microenvironment,” Cancer Cell, vol. 21, no. 3, pp. 309–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. W. Huo, G. L. Chew, and K. L. Britt, “Mammographic density: a review on the current understanding of its association with breast cancer,” Breast Cancer Research and Treatment, vol. 144, no. 3, pp. 479–502, 2014. View at Google Scholar
  36. K. Ghosh, K. R. Brandt, C. Reynolds et al., “Tissue composition of mammographically dense and non-dense breast tissue,” Breast Cancer Research and Treatment, vol. 131, no. 1, pp. 267–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Bissell and W. C. Hines, “Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression,” Nature Medicine, vol. 17, no. 3, pp. 320–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Keely, “Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion,” Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 3, pp. 205–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Paulsson and P. Micke, “Prognostic relevance of cancer-associated fibroblasts in human cancer,” Seminars in Cancer Biology, vol. 25, pp. 61–68, 2014. View at Publisher · View at Google Scholar
  40. M. A. Troester, M. H. Lee, M. Carter et al., “Activation of host wound responses in breast cancer microenvironment,” Clinical Cancer Research, vol. 15, no. 22, pp. 7020–7028, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. H. Manjili, K. Najarian, and X. Wang, “Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis,” Future Oncology, vol. 8, no. 6, pp. 703–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ahn, J. Cho, J. Sung et al., “The prognostic significance of tumor-associated stroma in invasive breast carcinoma,” Tumor Biology, vol. 33, no. 5, pp. 1573–1580, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Räsänen and A. Vaheri, “Activation of fibroblasts in cancer stroma,” Experimental Cell Research, vol. 316, no. 17, pp. 2713–2722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Xouri and S. Christian, “Origin and function of tumor stroma fibroblasts,” Seminars in Cell and Developmental Biology, vol. 21, no. 1, pp. 40–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. C. Monboisse, J. B. Oudart, L. Ramont, S. Brassart-Pasco, and F. X. Maquart, “Matrikines from basement membrane collagens: a new anti-cancer strategy,” Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2589–2598, 2014. View at Publisher · View at Google Scholar
  46. F. L. Miles and R. A. Sikes, “Insidious changes in stromal matrix fuel cancer progression,” Molecular Cancer Research, vol. 12, no. 3, pp. 297–312, 2014. View at Google Scholar
  47. J. Samples, M. Willis, and N. Klauber-Demore, “Targeting angiogenesis and the tumor microenvironment,” Surgical Oncology Clinics of North America, vol. 22, no. 4, pp. 629–639, 2013. View at Publisher · View at Google Scholar
  48. P. Heldin, K. Basu, B. Olofsson, H. Porsch, I. Kozlova, and K. Kahata, “Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer,” The Journal of Biochemistry, vol. 154, no. 5, pp. 395–408, 2013. View at Publisher · View at Google Scholar
  49. C. A. Maxwell, J. Benítez, L. Gómez-Baldó et al., “Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer,” PLoS Biology, vol. 9, no. 11, Article ID e1001199, 2011. View at Google Scholar
  50. A. C. Petrey and C. A. de la Motte, “Hyaluronan, a crucial regulator of inflammation,” Frontiers in Immunology, vol. 5, p. 101, 2014. View at Google Scholar
  51. D. Vigetti, E. Karousou, M. Viola, S. Deleonibus, G. De Luca, and A. Passi, “Hyaluronan: biosynthesis and signaling,” Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2452–2459, 2014. View at Google Scholar
  52. B. P. Toole and M. G. Slomiany, “Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells,” Seminars in Cancer Biology, vol. 18, no. 4, pp. 244–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. T. Dicker, L. A. Gurski, S. Pradhan-Bhatt, R. L. Witt, M. C. Farach-Carson, and X. Jia, “Hyaluronan: a simple polysaccharide with diverse biological functions,” Acta Biomaterialia, vol. 10, no. 4, pp. 1558–1570, 2014. View at Publisher · View at Google Scholar
  54. M. Veiseha, D. H. Kwona, A. D. Borowsky et al., “Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 17, pp. E1731–E1739, 2014. View at Publisher · View at Google Scholar
  55. C. Tolg, S. R. Hamilton, K. Nakrieko et al., “Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair,” Journal of Cell Biology, vol. 175, no. 6, pp. 1017–1028, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Tolg, P. Telmer, and E. Turley, “Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair,” PLoS ONE, vol. 9, no. 2, Article ID e88479, 2014. View at Google Scholar
  57. X. Ma, J. D. Pearce, D. B. Wilson, W. P. English, M. S. Edwards, and R. L. Geary, “Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling,” Journal of Vascular Surgery, vol. 59, no. 3, pp. 804–813, 2014. View at Publisher · View at Google Scholar
  58. J. P. Foley, D. Lam, H. Jiang et al., “Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein a-stimulated macrophage chemotaxis,” Journal of Biological Chemistry, vol. 287, no. 44, pp. 37406–37419, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Silverman-Gavrila, L. Silverman-Gavrila, and M. P. Bendeck, “Cell division fidelity is altered during the vascular response to injury: its novel role in atherosclerosis progression,” The American Journal of Pathology, vol. 182, no. 3, pp. 628–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Nedvetzki, E. Gonen, N. Assayag et al., “RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 52, pp. 18081–18086, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. C. A. Maxwell, J. McCarthy, and E. Turley, “Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?” Journal of Cell Science, vol. 121, no. 7, pp. 925–932, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Shigeishi, K. Higashikawa, and M. Takechi, “Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers,” Journal of Cancer Research and Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  63. M. S. Karbownik and J. Z. Nowak, “Hyaluronan: towards novel anti-cancer therapeutics,” Pharmacological Reports, vol. 65, no. 5, pp. 1056–1074, 2013. View at Google Scholar
  64. D. Nikitovic, K. Kouvidi, N. K. Karamanos, and G. N. Tzanakakis, “The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression,” BioMed Research International, vol. 2013, Article ID 929531, 12 pages, 2013. View at Publisher · View at Google Scholar
  65. B. P. Toole, “Hyaluronan: from extracellular glue to pericellular cue,” Nature Reviews Cancer, vol. 4, no. 7, pp. 528–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Jiang, J. Liang, and P. W. Noble, “Hyaluronan in tissue injury and repair,” Annual Review of Cell and Developmental Biology, vol. 23, pp. 435–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Tammi, S. Pasonen-Seppänen, E. Kolehmainen, and M. Tammi, “Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury,” Journal of Investigative Dermatology, vol. 124, no. 5, pp. 898–905, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. K. J. Bai, A. P. Spicer, M. M. Mascarenhas et al., “The role of hyaluronan synthase 3 in ventilator-induced lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 1, pp. 92–98, 2005. View at Google Scholar
  69. S. Karvinen, S. Pasonen-Seppänen, J. M. T. Hyttinen et al., “Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3,” The Journal of Biological Chemistry, vol. 278, no. 49, pp. 49495–49504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Kuroda, A. Utani, Y. Hamasaki, and H. Shinkai, “Up-regulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts,” Journal of Dermatological Science, vol. 26, no. 2, pp. 156–160, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. J. P. Pienimäki, K. Rilla, C. Fülöp et al., “Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan,” The Journal of Biological Chemistry, vol. 276, no. 23, pp. 20428–20435, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Yung, G. J. Thomas, and M. Davies, “Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro,” Kidney International, vol. 58, no. 5, pp. 1953–1962, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. C. I. Kennedy, R. F. Diegelmann, J. H. Haynes, and D. R. Yager, “Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts,” Journal of Pediatric Surgery, vol. 35, no. 6, pp. 874–879, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Auvinen, K. Rilla, R. Tumelius et al., “Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival,” Breast Cancer Research and Treatment, vol. 143, no. 2, pp. 277–286, 2014. View at Google Scholar
  75. S. Adamia, P. M. Pilarski, A. R. Belch, and L. M. Pilarski, “Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 347–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. R. H. Tammi, A. G. Passi, K. Rilla et al., “Transcriptional and post-translational regulation of hyaluronan synthesis,” FEBS Journal, vol. 278, no. 9, pp. 1419–1428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. T. K. Nykopp, K. Rilla, R. Sironen et al., “Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content,” BMC Cancer, vol. 9, article 143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Itano and K. Kimata, “Altered hyaluronan biosynthesis in cancer progression,” Seminars in Cancer Biology, vol. 18, no. 4, pp. 268–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. P. E. Pummill and P. L. DeAngelis, “Evaluation of critical structural elements of UDP-sugar substrates and certain cysteine residues of a vertebrate hyaluronan synthase,” The Journal of Biological Chemistry, vol. 277, no. 24, pp. 21610–21616, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Bonté, “Skin moisturization mechanisms: new data,” Annales Pharmaceutiques Francaises, vol. 69, no. 3, pp. 135–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Stern and H. I. Maibach, “Hyaluronan in skin: aspects of aging and its pharmacologic modulation,” Clinics in Dermatology, vol. 26, no. 2, pp. 106–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Verdier-Sévrain and F. Bonté, “Skin hydration: a review on its molecular mechanisms,” Journal of Cosmetic Dermatology, vol. 6, no. 2, pp. 75–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. T. D. Camenisch, J. Biesterfeldt, T. Brehm-Gibson, J. Bradley, and J. A. McDonald, “Regulation of cardiac cushion development by hyaluronan,” Experimental & Clinical Cardiology, vol. 6, no. 1, pp. 4–10, 2001. View at Google Scholar · View at Scopus
  84. T. D. Camenisch, A. P. Spicer, T. Brehm-Gibson et al., “Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme,” Journal of Clinical Investigation, vol. 106, no. 3, pp. 349–360, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. V. Goncharova, N. Serobyan, S. Iizuka et al., “Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis,” The Journal of Biological Chemistry, vol. 287, no. 30, pp. 25419–25433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Törrönen, K. Nikunen, R. Kärnä, M. Tammi, R. Tammi, and K. Rilla, “Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes,” Histochemistry and Cell Biology, vol. 141, no. 1, pp. 17–31, 2014. View at Publisher · View at Google Scholar
  87. J. Y. L. Tien and A. P. Spicer, “Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns,” Developmental Dynamics, vol. 233, no. 1, pp. 130–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Vigetti, M. Viola, E. Karousou, G. de Luca, and A. Passi, “Metabolic control of hyaluronan synthases,” Matrix Biology, vol. 35, pp. 8–13, 2014. View at Publisher · View at Google Scholar
  89. P. L. DeAngelis, “Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow,” Applied Microbiology and Biotechnology, vol. 94, no. 2, pp. 295–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. P. H. Weigel and P. L. DeAngelis, “Hyaluronan synthases: a decade-plus of novel glycosyltransferases,” The Journal of Biological Chemistry, vol. 282, no. 51, pp. 36777–36781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Inai, J. L. Burnside, S. Hoffman, B. P. Toole, and Y. Sugi, “BMP-2 induces versican and hyaluronan that contribute to post-EMT AV cushion cell migration,” PLoS ONE, vol. 8, no. 10, Article ID e77593, 2013. View at Publisher · View at Google Scholar
  92. Y. Hirose, E. Saijou, Y. Sugano et al., “Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 11, pp. 4263–4268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. H. C. Lien, Y. H. Lee, Y. M. Jeng, C. H. Lin, Y. S. Lu, and Y. T. Yao, “Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance,” Histopathology, 2014. View at Publisher · View at Google Scholar
  94. C. I. Kung, C. Chen, C. Yang, C. Lin, T. Chen, and H. Wang, “Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration,” Oncology Reports, vol. 28, no. 5, pp. 1808–1814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. S. R. Hamilton, S. F. Fard, F. F. Paiwand et al., “The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells,” The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16667–16680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Wang, Y. Wu, H. Wang et al., “Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 1, pp. E89–E98, 2014. View at Publisher · View at Google Scholar
  97. R. H. Tammi, A. Kultti, V. Kosma, R. Pirinen, P. Auvinen, and M. I. Tammi, “Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan,” Seminars in Cancer Biology, vol. 18, no. 4, pp. 288–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Stern, A. A. Asari, and K. N. Sugahara, “Hyaluronan fragments: an information-rich system,” European Journal of Cell Biology, vol. 85, no. 8, pp. 699–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. P. L. Bollyky, M. Bogdani, J. B. Bollyky, R. L. Hull, and T. N. Wight, “The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation,” Current Diabetes Reports, vol. 12, no. 5, pp. 471–480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. X. Tian, J. Azpurua, C. Hine et al., “High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat,” Nature, vol. 499, no. 7458, pp. 346–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. P. R. Esser, U. Wölfle, C. Dürr et al., “Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation,” PLoS ONE, vol. 7, no. 7, Article ID e41340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. M. E. Monzon, N. Fregien, N. Schmid et al., “Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation,” Journal of Biological Chemistry, vol. 285, no. 34, pp. 26126–26134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. F. Gao, J. R. Koenitzer, J. M. Tobolewski et al., “Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan,” The Journal of Biological Chemistry, vol. 283, no. 10, pp. 6058–6066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. M. D. Rees, C. L. Hawkins, and M. J. Davies, “Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates,” Biochemical Journal, vol. 381, part 1, pp. 175–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. C. C. Termeer, J. Hennies, U. Voith et al., “Oligosaccharides of hyaluronan are potent activators of dendritic cells,” Journal of Immunology, vol. 165, no. 4, pp. 1863–1870, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Tolg, S. R. Hamilton, E. Zalinska et al., “A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds,” The American Journal of Pathology, vol. 181, no. 4, pp. 1250–1270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Yuan, M. Tank, and A. Alsofyani, “Molecular mass dependence of hyaluronan detection by sandwich ELISA-like assay and membrane blotting using biotinylated hyaluronan binding protein,” Glycobiology, vol. 23, no. 11, pp. 1270–1280, 2013. View at Google Scholar
  108. S. M. Ruppert, T. R. Hawn, A. Arrigoni, T. N. Wight, and P. L. Bollyky, “Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation,” Immunologic Research, vol. 58, no. 2-3, pp. 186–192, 2014. View at Publisher · View at Google Scholar
  109. H. Urakawa, Y. Nishida, W. Knudson et al., “Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer,” Journal of Orthopaedic Research, vol. 30, no. 4, pp. 662–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. F. E. Lennon and P. A. Singleton, “Hyaluronan regulation of vascular integrity,” American Journal of Cardiovascular Disease, vol. 1, no. 3, pp. 200–213, 2011. View at Google Scholar
  111. R. D. Price, S. Myers, I. M. Leigh, and H. A. Navsaria, “The role of hyaluronic acid in wound healing: assessment of clinical evidence,” American Journal of Clinical Dermatology, vol. 6, no. 6, pp. 393–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. E. Hrabarova, I. Juranek, and L. Soltes, “Pro-oxidative effect of peroxynitrite regarding biological systems: a special focus on high-molar-mass hyaluronan degradation,” General Physiology and Biophysics, vol. 30, no. 3, pp. 223–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. L. Šoltés, R. Mendichi, G. Kogan, J. Schiller, M. Stankovská, and J. Arnhold, “Degradative action of reactive oxygen species on hyaluronan,” Biomacromolecules, vol. 7, no. 3, pp. 659–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton, “Hyaluronan fragments act as an endogenous danger signal by engaging TLR2,” The Journal of Immunology, vol. 177, no. 2, pp. 1272–1281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. C. A. de la Motte, “Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 301, no. 6, pp. G945–G949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. M. T. Kuipers, T. van der Poll, M. J. Schultz, and C. W. Wieland, “Bench-to-bedside review: damage-associated molecular patterns in the onset of ventilator-induced lung injury,” Critical Care, vol. 15, no. 6, article 235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. J. D. Powell and M. R. Horton, “Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal,” Immunologic Research, vol. 31, no. 3, pp. 207–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. K. Kishi, K. Okabe, R. Shimizu, and Y. Kubota, “Fetal skin possesses the ability to regenerate completely: Complete regeneration of skin,” Keio Journal of Medicine, vol. 61, no. 4, pp. 101–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Slevin, J. Krupinski, J. Gaffney et al., “Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways,” Matrix Biology, vol. 26, no. 1, pp. 58–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. T. N. Wight and S. Potter-Perigo, “The extracellular matrix: an active or passive player in fibrosis?” The American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 301, no. 6, pp. G950–G955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Jiang, J. Liang, and P. W. Noble, “Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan,” Anatomical Record, vol. 293, no. 6, pp. 982–985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. F. Gao, Y. Liu, Y. He et al., “Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis,” Matrix Biology, vol. 29, no. 2, pp. 107–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. F. Gao, C. X. Yang, W. Mo, Y. W. Liu, and Y. Q. He, “Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing,” Clinical and Investigative Medicine, vol. 31, no. 3, pp. E106–E116, 2008. View at Google Scholar · View at Scopus
  124. U. Anderegg, J. C. Simon, and M. Averbeck, “More than just a filler—the role of hyaluronan for skin homeostasis,” Experimental Dermatology, vol. 23, no. 5, pp. 295–303, 2014. View at Google Scholar
  125. A. Moustakas and P. Heldin, “TGFβ and matrix-regulated epithelial to mesenchymal transition,” Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2621–2634, 2014. View at Google Scholar
  126. R. Tammi, U. M. Agren, A. L. Tuhkanen, and M. Tammi, “Hyaluronan metabolism in skin,” Progress in Histochemistry and Cytochemistry, vol. 29, no. 2, pp. 1–81, 1994. View at Google Scholar · View at Scopus
  127. B. Wang, “Photoaging: a review of current concepts of pathogenesis,” Journal of Cutaneous Medicine and Surgery, vol. 15, supplement 1, pp. S374–S377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. A. Leung, T. M. Crombleholme, and S. G. Keswani, “Fetal wound healing: Implications for minimal scar formation,” Current Opinion in Pediatrics, vol. 24, no. 3, pp. 371–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Pasonen-Seppänen, J. M. T. Hyttinen, K. Rilla et al., “Role of CD44 in the organization of keratinocyte pericellular hyaluronan,” Histochemistry and Cell Biology, vol. 137, no. 1, pp. 107–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. J. Malaisse, V. Bourguignon, E. de Vuyst et al., “Hyaluronan Metabolism in Human Keratinocytes and Atopic Dermatitis Skin Is Driven by a Balance of Hyaluronan Synthases 1 and 3,” Journal of Investigative Dermatology, vol. 134, no. 8, pp. 2174–2182, 2014. View at Publisher · View at Google Scholar
  131. M. Kage, Y. Tokudome, Y. Matsunaga, T. Hariya, and F. Hashimoto, “Effect of hyaluronan tetrasaccharides on epidermal differentiation in normal human epidermal keratinocytes,” International Journal of Cosmetic Science, vol. 36, no. 1, pp. 109–115, 2014. View at Publisher · View at Google Scholar
  132. H. Choi, Y. Kang, J. Na et al., “Oligosaccharides of hyaluronic acid increased epidermal cell stemness by modulation of integrin expression,” Journal of Cosmetic Dermatology, vol. 11, no. 4, pp. 290–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Colello, S. Mathew, R. Ward, K. Pumiglia, and S. E. LaFlamme, “Integrins regulate microtubule nucleating activity of centrosome through mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signaling,” The Journal of Biological Chemistry, vol. 287, no. 4, pp. 2520–2530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. R. H. Tammi and M. I. Tammi, “Hyaluronan accumulation in wounded epidermis: a mediator of keratinocyte activation,” The Journal of Investigative Dermatology, vol. 129, no. 8, pp. 1858–1860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Xu, D. Baker, T. Quan, J. J. Baldassare, J. J. Voorhees, and G. J. Fisher, “Receptor type protein tyrosine phosphatase-κ mediates cross-talk between transforming growth factor-β and epidermal growth factor receptor signaling pathways in human keratinocytes,” Molecular Biology of the Cell, vol. 21, no. 1, pp. 29–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. M. L. Mancini and S. T. Sonis, “Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities,” Frontiers in Pharmacology, vol. 5, p. 51, 2014. View at Google Scholar
  137. G. S. Ashcroft, X. Yang, A. B. Glick et al., “Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response,” Nature Cell Biology, vol. 1, no. 5, pp. 260–266, 1999. View at Publisher · View at Google Scholar · View at Scopus
  138. A. C. Midgley, M. Rogers, M. B. Hallett et al., “Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts,” Journal of Biological Chemistry, vol. 288, no. 21, pp. 14824–14838, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. J. Webber, R. H. Jenkins, S. Meran, A. Phillips, and R. Steadman, “Modulation of TGFβ1-dependent myofibroblast differentiation by hyaluronan,” The American Journal of Pathology, vol. 175, no. 1, pp. 148–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. M. S. Hu, Z. N. Maan, J. C. Wu et al., “Tissue engineering and regenerative repair in wound healing,” Annals of Biomedical Engineering, vol. 42, no. 7, pp. 1494–1507, 2014. View at Publisher · View at Google Scholar
  141. C. Zgheib, J. Xu, and K. W. Liechty, “Targeting inflammatory cytokines and extracellular matrix composition to promote wound regeneration,” Advances in Wound Care, vol. 3, no. 4, pp. 344–355, 2014. View at Publisher · View at Google Scholar
  142. A. Orimo and R. A. Weinberg, “Stromal fibroblasts in cancer: a novel tumor-promoting cell type,” Cell Cycle, vol. 5, no. 15, pp. 1597–1601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. R. C. Caskey, M. Allukian, R. C. Lind et al., “Lentiviral-mediated over-expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair,” Cell and Tissue Research, vol. 351, no. 1, pp. 117–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Prosdocimi and C. Bevilacqua, “Exogenous hyaluronic acid and wound healing: an updated vision,” Panminerva Medica, vol. 54, no. 2, pp. 129–135, 2012. View at Google Scholar · View at Scopus
  145. G. M. Campo, A. Avenoso, A. D'Ascola et al., “Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis,” Archives of Biochemistry and Biophysics, vol. 518, no. 1, pp. 42–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. K. Ghazi, U. Deng-Pichon, J. Warnet, and P. Rat, “Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight,” PLoS ONE, vol. 7, no. 11, Article ID e48351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  147. C. de La Motte, J. Nigro, A. Vasanji et al., “Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines,” American Journal of Pathology, vol. 174, no. 6, pp. 2254–2264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  148. E. L. Ferguson, J. L. Roberts, R. Moseley, P. C. Griffiths, and D. W. Thomas, “Evaluation of the physical and biological properties of hyaluronan and hyaluronan fragments,” International Journal of Pharmaceutics, vol. 420, no. 1, pp. 84–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. M. David-Raoudi, F. Tranchepain, B. Deschrevel et al., “Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing,” Wound Repair and Regeneration, vol. 16, no. 2, pp. 274–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  150. G. Kaya, C. Tran, O. Sorg et al., “Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism,” PLoS Medicine, vol. 3, no. 12, article e493, pp. 2291–2303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. M. Wernicke, L. C. Piñeiro, D. Caramutti et al., “Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan,” Modern Pathology, vol. 16, no. 2, pp. 99–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. Y. Takahashi, H. Kuwabara, M. Yoneda, Z. Isogai, N. Tanigawa, and Y. Shibayama, “Versican G1 and G3 domains are upregulated and latent transforming growth factor-β binding protein-4 is downregulated in breast cancer stroma,” Breast Cancer, vol. 19, no. 1, pp. 46–53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. D. E. Costea, A. Hills, A. H. Osman et al., “Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma,” Cancer Research, vol. 73, no. 13, pp. 3888–3901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. H. Koyama, T. Hibi, Z. Isogai et al., “Hyperproduction of hyaluronan in Neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: Possible involvement of versican/PG-M,” The American Journal of Pathology, vol. 170, no. 3, pp. 1086–1099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. H. Koyama, N. Kobayashi, M. Harada et al., “Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment,” American Journal of Pathology, vol. 172, no. 1, pp. 179–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. P. Bono, V. Wasenius, P. Heikkilä, J. Lundin, D. G. Jackson, and H. Joensuu, “High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer,” Clinical Cancer Research, vol. 10, no. 21, pp. 7144–7149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. N. Kobayashi, S. Miyoshi, T. Mikami et al., “Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization,” Cancer Research, vol. 70, no. 18, pp. 7073–7083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. P. Auvinen, R. Tammi, V. Kosma et al., “Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer,” International Journal of Cancer, vol. 132, no. 3, pp. 531–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  159. J. I. Lopez, T. D. Camenisch, M. V. Stevens, B. J. Sands, J. McDonald, and J. A. Schroeder, “CD44 attenuates metastatic invasion during breast cancer progression,” Cancer Research, vol. 65, no. 15, pp. 6755–6763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  160. J. M. V. Louderbough and J. A. Schroeder, “Understanding the dual nature of CD44 in breast cancer progression,” Molecular Cancer Research, vol. 9, no. 12, pp. 1573–1586, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. N. Montgomery, A. Hill, S. McFarlane et al., “CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity,” Breast Cancer Research, vol. 14, no. 3, article R84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. V. Joukov, A. C. Groen, T. Prokhorova et al., “The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly,” Cell, vol. 127, no. 3, pp. 539–552, 2006. View at Publisher · View at Google Scholar · View at Scopus
  163. C. Hardwick, K. Hoare, R. Owens et al., “Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility,” Journal of Cell Biology, vol. 117, no. 6, pp. 1343–1350, 1992. View at Publisher · View at Google Scholar · View at Scopus
  164. B. Yang, L. Zhang, and E. A. Turley, “Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM,” The Journal of Biological Chemistry, vol. 268, no. 12, pp. 8617–8623, 1993. View at Google Scholar · View at Scopus
  165. C. Tolg, S. R. Hamilton, L. Morningstar et al., “RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity,” The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26461–26474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  166. C. A. Maxwell, J. J. Keats, A. R. Belch, L. M. Pilarski, and T. Reiman, “Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity,” Cancer Research, vol. 65, no. 3, pp. 850–860, 2005. View at Google Scholar · View at Scopus
  167. R. Forteza, T. Lieb, T. Aoki, R. C. Savani, G. E. Conner, and M. Salathe, “Hyaluronan serves a novel role in airway mucosal host defense,” The FASEB Journal, vol. 15, no. 12, pp. 2179–2186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Schoenfelder and R. Einspanier, “Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle,” Biology of Reproduction, vol. 69, no. 1, pp. 269–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  169. B. S. Kornovski, J. McCoshen, J. Kredentser, and E. Turley, “The regulation of sperm motility by a novel hyaluronan receptor,” Fertility and Sterility, vol. 61, no. 5, pp. 935–940, 1994. View at Google Scholar · View at Scopus
  170. D. Park, Y. Kim, H. Kim et al., “Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ,” Molecules and Cells, vol. 33, no. 6, pp. 563–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. D. Manzanares, M. Monzon, R. C. Savani, and M. Salathe, “Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON,” The American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 2, pp. 160–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  172. F. M. Amara, J. Entwistle, T. I. Kuschak, E. A. Turley, and J. A. Wright, “Transforming growth factor-β1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA,” The Journal of Biological Chemistry, vol. 271, no. 25, pp. 15279–15284, 1996. View at Publisher · View at Google Scholar · View at Scopus
  173. S. K. Samuel, R. A. R. Hurta, M. A. Spearman, J. A. Wright, E. A. Turley, and A. H. Greenberg, “TGF-β1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan,” Journal of Cell Biology, vol. 123, no. 3, pp. 749–758, 1993. View at Publisher · View at Google Scholar · View at Scopus
  174. Y. Buganim and V. Rotter, “RHAMM in the complex p53 cell cycle network,” Cell Cycle, vol. 7, no. 21, pp. 3287–3291, 2008. View at Google Scholar · View at Scopus
  175. S. Godar and R. A. Weinber, “Filling the mosaic of p53 actions: p53 represses RHAMM expression,” Cell Cycle, vol. 7, no. 22, p. 3479, 2008. View at Google Scholar · View at Scopus
  176. S. Sohr and K. Engeland, “RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53,” Cell Cycle, vol. 7, no. 21, pp. 3448–3460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. C. Tolg, R. Poon, R. Fodde, E. A. Turley, and B. A. Alman, “Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor),” Oncogene, vol. 22, no. 44, pp. 6873–6882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. J. Greiner, A. Schmitt, K. Giannopoulos et al., “High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma,” Haematologica, vol. 95, no. 7, pp. 1191–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Schmitt, A. Schmitt, M. T. Rojewski et al., “RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses,” Blood, vol. 111, no. 3, pp. 1357–1365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  180. T. C. Smith, Z. Fang, and E. J. Luna, “Novel interactors and a role for Supervillin in early cytokinesis,” Cytoskeleton, vol. 67, no. 6, pp. 346–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  181. R. C. Savani, C. Wang, B. Yang et al., “Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM,” Journal of Clinical Investigation, vol. 95, no. 3, pp. 1158–1168, 1995. View at Publisher · View at Google Scholar · View at Scopus
  182. S. Zhang, M. C. Y. Chang, D. Zylka, S. Turley, R. Harrison, and E. A. Turley, “The hyaluronan receptor RHAMM regulates extracellular-regulated kinase,” Journal of Biological Chemistry, vol. 273, no. 18, pp. 11342–11348, 1998. View at Publisher · View at Google Scholar · View at Scopus
  183. H. Hatano, H. Shigeishi, Y. Kudo et al., “RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR,” Laboratory Investigation, vol. 91, no. 3, pp. 379–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  184. Y. N. Du, C. Chou, D. S. Klimstra, and H. Varmus, “Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16753–16758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. R. C. Savani, G. Cao, P. M. Pooler, A. Zaman, Z. Zhou, and H. M. DeLisser, “Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis,” Journal of Biological Chemistry, vol. 276, no. 39, pp. 36770–36778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  186. V. B. Lokeshwar and M. G. Selzer, “Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells,” Journal of Biological Chemistry, vol. 275, no. 36, pp. 27641–27649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  187. C. L. Hall, F. S. Wang, and E. A. Turley, “Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment,” Cell Communication and Adhesion, vol. 9, no. 5-6, pp. 273–283, 2002. View at Publisher · View at Google Scholar · View at Scopus
  188. K. Kouvidi, A. Berdiaki, D. Nikitovic et al., “Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion,” Journal of Biological Chemistry, vol. 286, no. 44, pp. 38509–38520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. S. Mohapatra, X. Yang, J. A. Wright, E. A. Turley, and A. H. Greenberg, “Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression,” The Journal of Experimental Medicine, vol. 183, no. 4, pp. 1663–1668, 1996. View at Publisher · View at Google Scholar · View at Scopus
  190. P. E. A. Telmer, “RHAMM is required for MMP-9 expression and release from podosomes 10,” submitted, 2014.
  191. A. C. Groen, L. A. Cameron, M. Coughlin, D. T. Miyamoto, T. J. Mitchison, and R. Ohi, “XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly,” Current Biology, vol. 14, no. 20, pp. 1801–1811, 2004. View at Publisher · View at Google Scholar · View at Scopus
  192. H. Chen, P. Mohan, J. Jiang et al., “Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2,” Cell Cycle, vol. 13, no. 14, pp. 2248–2261, 2014. View at Google Scholar
  193. T. C. Smith, P. C. Fridy, Y. Li et al., “Supervillin binding to myosin II and synergism with anillin are required for cytokinesis,” Molecular Biology of the Cell, vol. 24, no. 23, pp. 3603–3619, 2013. View at Google Scholar
  194. S. S. Gangopadhyay, N. Takizawa, C. Gallant et al., “Smooth muscle archvillin: a novel regulator of signaling and contractility in vascular smooth muscle,” Journal of Cell Science, vol. 117, no. 21, pp. 5043–5057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  195. H. Hasegawa, T. Hyodo, E. Asano et al., “The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing,” Journal of Cell Science, vol. 126, no. 16, pp. 3627–3637, 2013. View at Publisher · View at Google Scholar · View at Scopus
  196. R. E. Harrison and E. A. Turley, “Active erk regulates microtubule stability in H-ras-transformed cells,” Neoplasia, vol. 3, no. 5, pp. 385–394, 2001. View at Publisher · View at Google Scholar · View at Scopus
  197. R. Silverman-Gavrila, L. Silverman-Gavrila, G. Hou, M. Zhang, M. Charlton, and M. P. Bendeck, “Rear polarization of the microtubule-organizing center in neointimal smooth muscle cells depends on PKCα, ARPC5, and RHAMM,” The American Journal of Pathology, vol. 178, no. 2, pp. 895–910, 2011. View at Publisher · View at Google Scholar · View at Scopus
  198. Y. Gouëffic, C. Guilluy, P. Guérin, P. Patra, P. Pacaud, and G. Loirand, “Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation,” Cardiovascular Research, vol. 72, no. 2, pp. 339–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  199. S. P. Evanko, T. Parks, and T. N. Wight, “Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle,” Journal of Histochemistry and Cytochemistry, vol. 52, no. 12, pp. 1525–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  200. P. Bhatia, M. Menigatti, M. Brocard, S. Morley, and S. Ferrari, “Mitotic DNA damage targets the Aurora A/TPX2 complex,” Cell Cycle, vol. 9, no. 22, pp. 4592–4599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  201. P. G. Telmer, C. Tolg, J. B. McCarthy, and E. A. Turley, “How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?” Communicative and Integrative Biology, vol. 4, no. 2, pp. 182–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  202. C. A. Maxwell, E. Rasmussen, F. Zhan et al., “RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma,” Blood, vol. 104, no. 4, pp. 1151–1158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  203. R. Zhou, X. Wu, and O. Skalli, “The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: Expression of a tumor-specific variant and association with microtubules,” Journal of Neuro-Oncology, vol. 59, no. 1, pp. 15–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  204. B. D. Lynn, X. Li, P. A. Cattini, E. A. Turley, and J. I. Nagy, “Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain,” Journal of Comparative Neurology, vol. 439, no. 3, pp. 315–330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  205. M. Crainie, A. R. Belch, M. J. Mant, and L. M. Pilarski, “Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants,” Blood, vol. 93, no. 5, pp. 1684–1696, 1999. View at Google Scholar · View at Scopus
  206. P. Mohan, J. Castellsague, J. Jiang et al., “Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition,” Oncotarget, vol. 4, no. 1, pp. 80–93, 2013. View at Google Scholar · View at Scopus
  207. V. Assmann, D. Jenkinson, J. F. Marshall, and I. R. Hart, “The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments,” Journal of Cell Science, vol. 112, part 22, pp. 3943–3954, 1999. View at Google Scholar · View at Scopus
  208. A. K. Dunsch, D. Hammond, J. Lloyd, L. Schermelleh, U. Gruneberg, and F. A. Barr, “Dynein light chain 1 and a spindle-associated adaptor promote dynein asymmetry and spindle orientation,” Journal of Cell Biology, vol. 198, no. 6, pp. 1039–1054, 2012. View at Publisher · View at Google Scholar · View at Scopus
  209. A. Zaman, Z. Cui, J. P. Foley et al., “Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury,” The American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 5, pp. 447–454, 2005. View at Publisher · View at Google Scholar · View at Scopus
  210. F. E. Lennon and P. A. Singleton, “Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 301, no. 2, pp. L137–L147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  211. S. Matou-Nasri, J. Gaffney, S. Kumar, and M. Slevin, “Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and γ-adducin,” International Journal of Oncology, vol. 35, no. 4, pp. 761–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  212. H. N. Lovvorn III, D. L. Cass, K. G. Sylvester et al., “Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia,” Journal of Pediatric Surgery, vol. 33, no. 7, pp. 1062–1070, 1998. View at Publisher · View at Google Scholar · View at Scopus
  213. K. K. Mantripragada, G. Spurlock, L. Kluwe et al., “High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization,” Clinical Cancer Research, vol. 14, no. 4, pp. 1015–1024, 2008. View at Publisher · View at Google Scholar · View at Scopus
  214. Y. Shi, T. Reiman, W. Li et al., “Targeting aurora kinases as therapy in multiple myeloma,” Blood, vol. 109, no. 9, pp. 3915–3921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  215. J. Tilghman, H. Wu, Y. Sang et al., “HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells,” Cancer Research, vol. 74, no. 11, pp. 3168–3179, 2014. View at Google Scholar
  216. A. E. Rizzardi, N. K. Rosener, J. S. Koopmeiners et al., “Evaluation of protein biomarkers of prostate cancer aggressiveness,” BMC Cancer, vol. 14, no. 1, article 244, 2014. View at Publisher · View at Google Scholar
  217. A. E. Rizzardi, R. Vogel, J. S. Koopmeiners et al., “Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors,” Cancer, vol. 120, no. 12, pp. 1800–1809, 2014. View at Publisher · View at Google Scholar
  218. C. Wang, A. D. Thor, D. H. Moore II et al., “The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression,” Clinical Cancer Research, vol. 4, no. 3, pp. 567–576, 1998. View at Google Scholar · View at Scopus